Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Hikma Pharmaceutical (HKMPF)

Hikma Pharmaceutical (HKMPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,051,513
  • Shares Outstanding, K 242,320
  • Annual Sales, $ 2,207 M
  • Annual Income, $ 486,000 K
  • 60-Month Beta 0.42
  • Price/Sales 3.51
  • Price/Cash Flow 17.08
  • Price/Book 3.31
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/02/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.2000 +11.07%
on 07/13/20
33.0000 -11.82%
on 08/11/20
+1.6000 (+5.82%)
since 07/02/20
3-Month
26.2000 +11.07%
on 07/13/20
42.0000 -30.71%
on 06/17/20
-1.0000 (-3.32%)
since 05/08/20
52-Week
19.7500 +47.34%
on 03/23/20
42.0000 -30.71%
on 06/17/20
+6.6500 (+29.62%)
since 07/30/19

Most Recent Stories

More News
Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication, by Age Group, by Class, by Route, by Distrubution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ -- Read the full report: The Global Inhalation & Nasal Sprays Generic Drugs Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.03%.Market...

AGN : 193.02 (+0.02%)
HKMPF : 29.1000 (-9.06%)
PRGO : 52.63 (-1.11%)
Rigel Pharmaceuticals (RIGL) Looks Good: Stock Adds 9.7% in Session

Rigel Pharmaceuticals (RIGL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

RIGL : 2.51 (+0.40%)
HKMPF : 29.1000 (-9.06%)
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.

Amarin Corporation plc (NASDAQ:AMRN) announced today a settlement agreement with Apotex Inc. (Apotex) that resolves patent litigation that would have resulted from the previously disclosed abbreviated...

HKMPF : 29.1000 (-9.06%)
AMRN : 6.76 (+2.11%)
Musculoskeletal Medicine Market Research Report 2020-2026: By Product, Application, Manufacturer, Sales and Segmentation

A recent report provides crucial insights along with application based and forecast information in the Global Musculoskeletal Medicine Market. The report provides a comprehensive analysis of key factors...

ACOR : 0.6970 (+1.32%)
HKMPF : 29.1000 (-9.06%)
MRK : 83.54 (+1.04%)
NVS : 85.37 (+0.52%)
TEVA : 11.57 (-0.60%)
VRX.TO : 30.80 (-3.33%)
Hydroxychloroquine Markets to 2027 - COVID-19 Applications Have Spurred Favorable Growth

, /PRNewswire/ -- The report has been added to offering.

HKMPF : 29.1000 (-9.06%)
NVS : 85.37 (+0.52%)
SHPMY : 9.1000 (-5.31%)
TEVA : 11.57 (-0.60%)
Premier Inc. ProvideGx(TM) Program Partners with Hikma Pharmaceuticals to Secure the Supply of Two Drugs Essential for COVID-19 Patient Care

Premier Inc. (NASDAQ: PINC), through its ProvideGx(TM) program, has partnered with Hikma Pharmaceuticals PLC (Hikma, Group) to supply amiodarone and sterile water to healthcare providers, helping to stabilize...

HKMPF : 29.1000 (-9.06%)
PINC : 35.30 (+1.67%)
Hikma launches Dicyclomine Hydrochloride Oral Solution

, /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, has launched Dicyclomine Hydrochloride Oral Solution, USP, 10 mg/5 mL, an AA-rated version of...

HKMPF : 29.1000 (-9.06%)
HKMPY : 61.4000 (-3.23%)
Hikma launches Dicyclomine Hydrochloride Oral Solution

LONDON , May 28, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, has launched Dicyclomine Hydrochloride Oral Solution, USP, 10 mg/5 mL,...

HKMPF : 29.1000 (-9.06%)
HKMPY : 61.4000 (-3.23%)
Hikma receives FDA approval for its generic Vascepa®

, /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals Inc. has received approval...

HKMPF : 29.1000 (-9.06%)
HKMPY : 61.4000 (-3.23%)
Hikma receives FDA approval for its generic Vascepa®

LONDON , May 22, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals...

HKMPF : 29.1000 (-9.06%)
HKMPY : 61.4000 (-3.23%)
Trade HKMPF with:

Key Turning Points

2nd Resistance Point 34.4200
1st Resistance Point 31.7600
Last Price 29.1000
1st Support Level 27.6800
2nd Support Level 26.2600

See More

52-Week High 42.0000
Fibonacci 61.8% 33.5005
Fibonacci 50% 30.8750
Last Price 29.1000
Fibonacci 38.2% 28.2495
52-Week Low 19.7500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar